Menu

Latest news & events

Professorship Julie Staals

Professorship Julie Staals

22 April 2024

Dr Julie Staals (Dept. of Neurology) has been appointed as professor 'Neurovascular disease' as of 1 April 2024.

Read more
ERC Advanced Grant awarded to Prof. Andy Baker

ERC Advanced Grant awarded to Prof. Andy Baker

15 April 2024

Prof. Andy Baker (Dept of Pathology) has been awarded a European Research Council (ERC) Advanced Grant of €2,5M for his research project PolymiRize: Poly-miRNA targeting to prevent and reverse complex tissue remodelling after acute cardiovascular events'.

Read more
More newsMore events
Carim Maastricht
Carim Maastricht

Thomas Van Sloten

Post doc

Dr Thomas van Sloten studied Medicine at Maastricht University and Clinical Epidemiology at VU University Amsterdam, both in the Netherlands. The focus of his research is the epidemiological study of the role of microvascular dysfunction in the development brain diseases, including stroke, dementia and depression.

He did his PhD research under supervision of Prof. Coen Stehouwer at the Department of Internal Medicine of Maastricht UMC+, within CARIM. Thomas also worked at the National Institutes of Health (USA) and at INSERM U970, Paris Cardiovascular Research Center (France).

Currently, Thomas works as a resident internal medicine and post-doctoral research fellow with a Tenure-track position at Maastricht UMC+. Thomas has been awarded with various grants, including a Veni grant (Dutch Research Council NWO talent scheme), a Dekker clinical scientist grant (Dutch Heart Foundation) and a Diabetes Fonds Junior Fellowship (Dutch Diabetes Research Foundation).

Thomas-van-sloten

Department of Internal Medicine
Randwycksingel 35, 6229 EG Maastrichtl
T: +31(0)621 214 590

  • 2017
    • Stehouwer, C. D. A., & van Sloten, T. T. (2017). Microvascular outcomes in type 2 diabetes. The Lancet Diabetes & Endocrinology, 5(8), 579-579. https://doi.org/10.1016/S2213-8587(17)30187-0
    • Veugen, M. G. J., Henry, R. M. A., van Sloten, T. T., Hermeling, E., Brunner-La Rocca, H.-P., Schram, M. T., Dagnelie, P. C., Schalkwijk, C. G., Kroon, A. A., Stehouwer, C. D. A., & Reesink, K. D. (2017). The systolic-diastolic difference in carotid stiffness is increased in type 2 diabetes: The Maastricht Study. Journal of Hypertension, 35(5), 1052-1060. https://doi.org/10.1097/HJH.0000000000001298
  • 2016
    • Geijselaers, S. L. C., Sep, S. J. S., Schram, M. T., van Boxtel, M. P. J., van Sloten, T. T., Henry, R. M. A., Reesink, K. D., Kroon, A. A., Koster, A., Schaper, N. C., Dagnelie, P. C., van der Kallen, C. J. H., Biessels, G. J., & Stehouwer, C. D. A. (2016). Carotid stiffness is associated with impairment of cognitive performance in individuals with and without type 2 diabetes. The Maastricht Study. Atherosclerosis, 253, 186-193. https://doi.org/10.1016/j.atherosclerosis.2016.07.912
    • van Eupen, M. G. A., Schram, M. T., van Sloten, T. T., Scheijen, J., Sep, S. J. S., van der Kallen, C. J., Dagnelie, P. C., Koster, A., Schaper, N., Henry, R. M. A., Kroon, A. A., Smit, A. J., Stehouwer, C. D. A., & Schalkwijk, C. G. (2016). Skin Autofluorescence and Pentosidine Are Associated With Aortic Stiffening: The Maastricht Study. Hypertension, 68(4), 956-963. https://doi.org/10.1161/HYPERTENSIONAHA.116.07446
    • van Sloten, T. T., Mitchell, G. F., Sigurdsson, S., van Buchem, M. A., Jonsson, P. V., Garcia, M. E., Harris, T. B., Henry, R. M. A., Levey, A. S., Stehouwer, C. D. A., Gudnason, V., & Launer, L. J. (2016). Associations between arterial stiffness, depressive symptoms and cerebral small vessel disease: cross-sectional findings from the AGES-Reykjavik Study. Journal of Psychiatry & Neuroscience, 41(3), 162-168. https://doi.org/10.1503/jpn.140334
    • van Sloten, T. T., & Stehouwer, C. D. A. (2016). Carotid Stiffness: A Novel Cerebrovascular Disease Risk Factor. Pulse, 4(1), 24-27. https://doi.org/10.1159/000445354
  • 2015
    • van Sloten, T. T., Sedaghat, S., Laurent, S., London, G. M., Pannier, B., Ikram, M. A., Kavousi, M., Mattace-Raso, F., Franco, O. H., Boutouyrie, P., & Stehouwer, C. D. A. (2015). Carotid Stiffness Is Associated With Incident Stroke A Systematic Review and Individual Participant Data Meta-Analysis. Journal of the American College of Cardiology, 66(19), 2116-2125. https://doi.org/10.1016/j.jacc.2015.08.888
    • Wijnands, J. M. A., Boonen, A., van Sloten, T. T., Schram, M. T., Sep, S. J. S., Koster, A., van der Kallen, C. J. H., Henry, R. M. A., Dagnelie, P. C., Stehouwer, C. D. A., van der Linden, S., & Arts, I. C. W. (2015). Association between serum uric acid, aortic, carotid and femoral stiffness among adults aged 40-75 years without and with type 2 diabetes mellitus: The Maastricht Study. Journal of Hypertension, 33(8), 1642-1650. https://doi.org/10.1097/HJH.0000000000000593
    • van Sloten, T. T., Czernichow, S., Houben, A. J., Protogerou, A. D., Henry, R. M., Muris, D. M., Schram, M. T., Sep, S. J., Dagnelie, P. C., van der Kallen, C. J., Schaper, N. C., Blacher, J., Hercberg, S., Levy, B. I., & Stehouwer, C. D. (2015). Association Between Arterial Stiffness and Skin Microvascular Function: The SUVIMAX2 Study and The Maastricht Study. American Journal of Hypertension, 28(7), 868-876. https://doi.org/10.1093/ajh/hpu246
    • van Sloten, T. T., Protogerou, A. D., Henry, R. M. A., Schram, M. T., Launer, L. J., & Stehouwer, C. D. A. (2015). Association between arterial stiffness, cerebral small vessel disease and cognitive impairment: A systematic review and meta-analysis. Neuroscience and Biobehavioral Reviews, 53, 121-130. https://doi.org/10.1016/j.neubiorev.2015.03.011
    • van Sloten, T. T., Sigurdsson, S., van Buchem, M. A., Phillips, C. L., Jonsson, P. V., Ding, J., Schram, M. T., Harris, T. B., Gudnason, V., & Launer, L. J. (2015). Cerebral Small Vessel Disease and Association With Higher Incidence of Depressive Symptoms in a General Elderly Population: The AGES-Reykjavik Study. American Journal of Psychiatry, 172(6), 570-578. https://doi.org/10.1176/appi.ajp.2014.14050578
    • van Sloten, T. T., & Stehouwer, C. D. A. (2015). Effects of RAS inhibitors on diabetic retinopathy Reply. The Lancet Diabetes & Endocrinology, 3(5), 316-316. https://doi.org/10.1016/S2213-8587(15)00084-4
    • van Sloten, T. T., & Stehouwer, C. D. A. (2015). No need to change guidelines for diabetic retinopathy and renin-angiotensin system inhibitors. The Lancet Diabetes & Endocrinology, 3(4), 231-232. https://doi.org/10.1016/S2213-8587(15)70006-9
  • 2014
    • van Sloten, T. T., Henry, R. M. A., Dekker, J. M., Nijpels, G., Unger, T., Schram, M. T., & Stehouwer, C. D. A. (2014). Endothelial Dysfunction Plays a Key Role in Increasing Cardiovascular Risk in Type 2 Diabetes The Hoorn Study. Hypertension, 64(6), 1299-U293. https://doi.org/10.1161/HYPERTENSIONAHA.114.04221
    • van Sloten, T. T., Schram, M. T., van den Hurk, K., Dekker, J. M., Nijpels, G., Henry, R. M. A., & Stehouwer, C. D. A. (2014). Local Stiffness of the Carotid and Femoral Artery Is Associated With Incident Cardiovascular Events and All-Cause Mortality The Hoorn Study. Journal of the American College of Cardiology, 63(17), 1739-1747. https://doi.org/10.1016/j.jacc.2013.12.041
    • van Sloten, T. T., Schram, M. T., Adriaanse, M. C., Dekker, J. M., Nijpels, G., Teerlink, T., Scheffer, P. G., Pouwer, F., Schalkwijk, C. G., Stehouwer, C. D. A., & Henry, R. M. A. (2014). Endothelial dysfunction is associated with a greater depressive symptom score in a general elderly population: the Hoorn Study. Psychological Medicine, 44(7), 1403-1416. https://doi.org/10.1017/S0033291713002043
  • 2012
    • van Sloten, T. T., Pijpers, E., Stehouwer, C. D. A., & Brouwers, M. C. (2012). Metformin-associated lactic acidosis in a patient with normal kidney function.Diabetes Research and Clinical Practice, 96(3), E57-E58. https://doi.org/10.1016/j.diabres.2011.07.021
  • 2011
    • van Sloten, T. T., Savelberg, H. H., Duimel-Peeters, I. G. M., Meijer, K., Henry, R. M., Stehouwer, C. D. A., & Schaper, N. C. (2011). Peripheral neuropathy, decreased muscle strength and obesity are strongly associated with walking in persons with type 2 diabetes without manifest mobility limitations.Diabetes Research and Clinical Practice, 91(1), 32-39. https://doi.org/10.1016/j.diabres.2010.09.030
Overview